725613591	725613591	CD	B-NP	O
|	|	NN	I-NP	O
OMC	OMC	NN	I-NP	O
|	|	NN	I-NP	O
18812086	18812086	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4836784	4836784	CD	B-NP	O
|	|	CC	I-NP	O
9/23/2006	9/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ABDOMINAL	ABDOMINAL	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/21/2006	7/21/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2006	1/18/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MONTESINOS	MONTESINOS	NN	B-NP	O
,	,	,	O	O
DANA	DANA	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
+	+	SYM	I-NP	O
-	-	HYPH	I-NP	O
year-old	year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
delta	delta	NN	I-NP	O
MS	MS	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
posterior	posterior	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
infarcts	infarct	NNS	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
embolic	embolic	JJ	I-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
yesterday	yesterday	NN	B-NP	O
and	and	CC	O	O
now	now	RB	B-VP	O
presents	present	VBZ	I-VP	O
with	with	IN	B-PP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
shaking	shake	VBG	B-VP	O
,	,	,	O	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
also	also	RB	B-ADVP	O
,	,	,	O	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	I-VP	O
sputum	sputum	NN	B-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
question	question	NN	B-NP	O
aspiration	aspiration	NN	I-NP	O
event	event	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
his	his	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
PFO	PFO	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
hypertensive	hypertensive	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
to	to	TO	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
240	240	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
.	.	.	O	O

Had	Have	VBD	O	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
to	to	TO	B-PP	O
peak	peak	NN	B-NP	O
of	of	IN	B-PP	O
1.94	1.94	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
demand	demand	NN	B-NP	O
related	relate	VBN	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
walks	walk	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
requires	require	VBZ	B-VP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
ADLs	ADL	NNS	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
101.3	101.3	CD	B-NP	O
,	,	,	O	O
axillary	axillary	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
80s	80	NNS	I-NP	O
to	to	TO	B-PP	O
90s	90	NNS	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
180s/80s	180s/80	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
quite	quite	RB	B-ADJP	O
distended	distended	JJ	I-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
not	not	RB	O	O
rigid	rigid	JJ	B-ADJP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
signs	sign	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
hemiarthroplasty	hemiarthroplasty	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Non	Non	JJ	B-NP	O
insulin-dependent	insulin-dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Psoriasis	Psoriasis	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Leiomyoma	Leiomyoma	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

SVT	SVT	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.3	1.3	CD	B-NP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Embolic	Embolic	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
2006	2006	CD	B-NP	O
.	.	.	O	O

IMPORTANT	IMPORTANT	JJ	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
PA	PA	NNP	I-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
dated	date	VBN	I-NP	O
1/10/06	1/10/06	CD	I-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
opacification	opacification	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
view	view	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
base	base	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
,	,	,	O	O
atelectasis	atelectasis	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lung	lung	NN	I-NP	O
,	,	,	O	O
tiny	tiny	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
are	be	VBP	B-VP	O
possible	possible	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
heart	heart	NN	B-NP	O
size	size	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
on	on	IN	B-PP	O
3/1/06	3/1/06	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Contracted	Contract	VBD	B-VP	O
gallbladder	gallbladder	NN	B-NP	O
with	with	IN	B-PP	O
gallstones	gallstone	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sonographic	sonographic	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
-RRB-	-RRB-	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

KUB	KUB	NN	B-NP	B-protein
dated	date	VBD	B-VP	O
4/5/06	4/5/06	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
subdiaphragmatic	subdiaphragmatic	JJ	I-NP	O
air	air	NN	I-NP	O
is	be	VBZ	B-VP	O
seen	see	VBN	I-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
high-grade	high-grade	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
limited	limited	JJ	B-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
motion	motion	NN	B-NP	O
artifact	artifact	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
4/5/06	4/5/06	CD	B-NP	O
,	,	,	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
pansensitive	pansensitive	JJ	I-NP	O
E.	E.	NNP	I-NP	O
coli	coli	NNP	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
pansensitive	pansensitive	JJ	I-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
UTI	UTI	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
likely	likely	RB	I-VP	O
been	be	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
aspiration	aspiration	NN	B-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
recent	recent	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
and	and	CC	O	O
documented	document	VBD	B-VP	O
aspiration	aspiration	NN	B-NP	O
by	by	IN	B-PP	O
Speech	Speech	NN	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NN	I-NP	O
on	on	IN	B-PP	O
previous	previous	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
19.8	19.8	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Levaquin	Levaquin	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
Levaquin	Levaquin	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
cover	cover	VB	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
11/16/06	11/16/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GU	GU	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
1.5	1.5	CD	B-NP	O
mL	mL	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
bladder	bladder	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
indicating	indicate	VBG	I-VP	O
significant	significant	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
drained	drain	VBD	B-VP	O
the	the	DT	B-NP	O
urine	urine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Flomax	Flomax	NN	B-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	O
recovery	recovery	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
urethral	urethral	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

Most	Most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
underlying	underlie	VBG	I-VP	O
urinary	urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
exacerbated	exacerbate	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
Foley	Foley	NNP	I-NP	O
placement	placement	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Then	Then	RB	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
without	without	IN	B-PP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
note	note	NN	I-NP	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
void	void	VB	I-VP	O
several	several	JJ	B-NP	O
times	time	NNS	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
urinary	urinary	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
likely	likely	RB	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
requiring	require	VBG	B-VP	O
readmission	readmission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
until	until	IN	B-SBAR	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
four	four	CD	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
out	out	IN	B-PRT	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
void	void	VB	I-VP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
bladder	bladder	NN	I-NP	O
scan	scan	NN	I-NP	O
ten	ten	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
out	out	RP	B-PRT	O
revealed	reveal	VBD	B-VP	O
432	432	CD	B-NP	O
mL	mL	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
bladder	bladder	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
bladder	bladder	NN	I-NP	O
and	and	CC	I-NP	O
Urology	Urology	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
recommended	recommend	VBD	B-VP	O
bladder	bladder	NN	B-NP	O
rest	rest	NN	I-NP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
meaning	mean	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Booker	Booker	NNP	I-NP	O
Randgaard	Randgaard	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
still	still	RB	B-ADVP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
for	for	IN	B-SBAR	O
a	a	DT	B-NP	O
voiding	void	VBG	I-NP	O
trial	trial	NN	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
2.2	2.2	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
significantly	significantly	RB	B-ADVP	O
above	above	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
steadily	steadily	RB	B-ADVP	O
declined	decline	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
within	within	IN	B-PP	O
his	his	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
SBPs	SBP	NNS	B-NP	B-protein
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
200	200	CD	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
such	such	JJ	B-NP	O
that	that	IN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
is	be	VBZ	B-VP	O
Lopressor	Lopressor	NNP	B-NP	O
50	50	CD	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
and	and	CC	I-NP	O
Norvasc	Norvasc	NN	I-NP	O
10	10	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
during	during	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
ranged	range	VBN	I-VP	O
from	from	IN	B-PP	O
110	110	CD	B-NP	O
to	to	TO	B-PP	O
140/70s	140/70s	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
ranged	range	VBD	B-VP	O
64	64	CD	B-NP	O
to	to	TO	B-PP	O
82	82	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
and	and	CC	O	O
his	his	PRP$	B-NP	O
p.o.	p.o.	FW	I-NP	O
regimen	regimen	NN	I-NP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
12	12	CD	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
tolbutamide	tolbutamide	NN	B-NP	O
500	500	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
steadily	steadily	RB	I-NP	O
rising	rise	VBG	I-NP	O
alk	alk	NN	I-NP	O
phos	pho	NNS	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
206	206	CD	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
508	508	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
GGT	GGT	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
119	119	CD	B-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
completed	complete	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
contracted	contract	VBN	I-NP	O
gallbladder	gallbladder	NN	I-NP	O
with	with	IN	B-PP	O
gallstones	gallstone	NNS	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
constipated	constipate	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
Dulcolax	Dulcolax	NN	I-NP	O
suppository	suppository	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
worked	work	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
Lovenox	Lovenox	NN	B-NP	O
subcu	subcu	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
DNI	DNI	NN	B-NP	O
though	though	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
want	want	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
resuscitated	resuscitate	VBN	I-VP	O
with	with	IN	B-PP	O
CPR	CPR	NN	B-NP	B-protein
,	,	,	O	O
defibrillated	defibrillate	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
given	give	VBN	B-NP	O
pressors	pressor	NNS	I-NP	O
.	.	.	O	O

CONTACT	CONTACT	NN	B-NP	O
INFORMATION	INFORMATION	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Olen	Olen	NNP	I-NP	O
Stroebel	Stroebel	NNP	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
at	at	IN	B-PP	O
471-446-0880	471-446-0880	CD	B-NP	O
or	or	CC	I-NP	O
167-100-0595	167-100-0595	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
wife	wife	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
at	at	IN	B-PP	O
081-581-0406	081-581-0406	CD	B-NP	O
.	.	.	O	O

FINAL	FINAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Urinary	Urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	VBP	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
TO	TO	NN	I-NP	O
REHAB	REHAB	NN	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.	p.r.	RB	B-ADVP	O
b.i.d.	b.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Mag	Mag	NNP	B-NP	O
sulfate	sulfate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
IV	IV	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
50	50	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NNP	B-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
tolbutamide	tolbutamide	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
triamcinolone	triamcinolone	NN	B-NP	O
topical	topical	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10	10	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
30	30	CD	I-NP	O
subcu	subcu	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
risperidone	risperidone	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Dovonex	Dovonex	NNP	B-NP	O
ointment	ointment	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Remeron	Remeron	NNP	B-NP	O
15	15	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Zyprexa	Zyprexa	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
or	or	CC	I-NP	O
agitation	agitation	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x5	x5	CD	I-NP	O
doses	dose	NNS	I-NP	O
to	to	TO	B-VP	O
finish	finish	VB	I-VP	O
on	on	IN	B-PP	O
2/24/06	2/24/06	CD	B-NP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/3	3/3	CD	I-NP	O
.5	.5	CD	I-NP	O
nebs	neb	NNS	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
a.c.	a.c.	NN	I-NP	O
and	and	CC	I-NP	O
nighttime	nighttime	NN	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
APPOINTMENT	APPOINTMENT	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Coric	Coric	NNP	I-NP	O
on	on	IN	B-PP	O
8/13/06	8/13/06	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
.	.	.	O	O

Thank	Thank	VB	B-VP	O
you	you	PRP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
opportunity	opportunity	NN	I-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
part	part	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-5072274	5-5072274	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LAROE	LAROE	NNP	B-NP	O
,	,	,	O	O
MOSE	MOSE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BINETTE	BINETTE	NNP	B-NP	O
,	,	,	O	O
WILL	WILL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2870427	2870427	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/1/06	3/1/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/1/06	3/1/06	CD	B-NP	O

